Psychological distress in breast cancer patients during oncological inpatient rehabilitation: incidence, triggering factors and correlation with treatment-induced side effects.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
03 2023
Historique:
received: 11 02 2022
accepted: 01 06 2022
pubmed: 23 6 2022
medline: 8 3 2023
entrez: 22 6 2022
Statut: ppublish

Résumé

As a result of the cancer diagnosis and the mostly multimodal, stressful therapy, psychological distress is a common symptom in breast cancer patients. As part of this prospective study, 1400 patients who were admitted to the hospital for oncological rehabilitation were screened for distress and somatic, therapy-induced secondary disorders. Mean distress in the screened population was 5.6 ± 2.56 (range 0-10). In 942 cases (67.3%) a significant distress score (≥ 5) was detected and in 587 cases (41.9%) very high levels of distress (≥ 7) was observed. Psychological distress significantly correlated with younger age, presence of triple negative breast cancer (TNBC), tumor recurrence and metastasis, and inability to work. Treatment-induced side effects such as lymphedema, CIPN or extensive tumor resection (mastectomy) showed a (not significant) trend for higher distress. The high incidence of distress underscores the importance of psycho-oncological therapy offers and the great importance of occupational measures during oncological rehabilitation such as the importance of a successful return to work for a better quality of life in breast cancer patients.

Identifiants

pubmed: 35732979
doi: 10.1007/s00404-022-06657-3
pii: 10.1007/s00404-022-06657-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

919-925

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Brustkrebs (Mammakarzinom). Zentrum für Krebsregisterdaten, Robert Koch-Institut. 2019.
Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland eV Hrsg. Berlin: Krebs in Deutschland 2007/2008. 2012.
Hass HG (2019) Früh- und Spättoxizitäten nach multimodaler brustkrebsbehandlung in der onkologischen rehabilitation—auswertung von 5.800 patientenfällen. Gynäkologische Praxis. 45:88–99
Schubart JR, Emerich M, Farnan M et al (2014) Screening for psychological distress in surgical breast cancer patients. Ann Surg Oncol 21:3348–3353
doi: 10.1245/s10434-014-3919-8 pubmed: 25034820
Mehnert A, Hartung TJ, Friedrich M, Vehling S, Brahler E, Harter M et al (2018) One in two cancer patients is significantly distressed: prevalence and indicators of distress. Psychooncology 27:75–82. https://doi.org/10.1002/pon.4464
doi: 10.1002/pon.4464 pubmed: 28568377
Brown KW, Levy AR, Rosberger Z, Edgar L (2003) Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychos Med 65:636–643. https://doi.org/10.1097/01.psy.0000077503.96903
doi: 10.1097/01.psy.0000077503.96903
Mehnert A, Brahler E, Faller H, Harter M, Keller M, Schulz H et al (2014) Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 32:3540–3546. https://doi.org/10.1200/JCO.2014.56.0086
doi: 10.1200/JCO.2014.56.0086 pubmed: 25287821
Werner A, Stenner C, Schüz J (2012) Patient versus clinician symptom reporting: how accurate is the detection of distress in the oncologic after-care? Psychooncology 21:818–826. https://doi.org/10.1002/pon.1975
doi: 10.1002/pon.1975 pubmed: 21544897
Holland JC (2013) Distress screening and the integration of psychosocial care into routine oncologic care. J Natl Compr Canc Netw 11(5 Suppl.):687–689. https://doi.org/10.6004/jnccn.2013
doi: 10.6004/jnccn.2013 pubmed: 23704244
Nationale Comprehensive Cancer Network [NCCN] (2004). The Nationale Comprehensive Cancer Network and the American Cancer Society. Distress Treatment Guidelines for Patients.Plymouth: NCCN.
Mehnert A, Müller D, Lehmann C, Koch U (2006) Die deutsche version des NCCN distress-thermometers. empirische prüfung eines screening–instruments zur erfassung psychosozialer belastung bei krebspatienten. Z Psychiatr Psychol Psychother. 54:213–223
Cormio C, Caporale F, Spatuzzi R, Lagattolla F, Lisi A, Graziano G (2019) Psychosocial distress in oncology: using the distress thermometer for assessing risk classes. Support Care Cancer 27:4115–4121
doi: 10.1007/s00520-019-04694-4 pubmed: 30788626
Peters L, Brederecke J, Franzke A, de Zwaan M, Zimmermann T (2020) Psychological distress in a sample of inpatients with mixed cancer–a cross–sectional study of routine clinical data. Front Psychol 30(11):591771
doi: 10.3389/fpsyg.2020.591771
Ciambella CC, Taneja C, Dizon DS, Wiggins DL, Emmick CM, Leonard KL, Lopresti ML, Witherby S, Cabral D, Snow S, Graves TA (2019) Distress: characterizing what causes the thermometer to shift in patients with newly diagnosed breast cancer attending a multidisciplinary clinic. Ann Surg Oncol 26:3204–3209
doi: 10.1245/s10434-019-07544-z pubmed: 31342366
Perez-Tejada J, Labaka A, Pascual-Sagastizabal E, Garmendia L, Iruretagoyena A, Arregi A (2019) Predictors of psychological distress in breast cancer survivors: a biopsychosocial approach. Eur J Cancer Care 28:e13166
doi: 10.1111/ecc.13166
Hong JS, Tian J, Wu LH (2014) The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. Curr Oncol 21:174–180
doi: 10.3747/co.21.1984 pubmed: 25089099 pmcid: 4117615
Bjerkeset E, Röhrl K, Schou-Bredal I (2020) Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics. Breast Cancer Res Treat 180:63–71
doi: 10.1007/s10549-020-05522-8 pubmed: 31938939 pmcid: 7031174
Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159:327–333
doi: 10.1007/s10549-016-3939-0 pubmed: 27510185 pmcid: 5509538
Alcorso J, Sherman KA (2016) Factors associated with psychological distress in women with breast cancer–related lymphoedema. Psychooncology 25:865–872
doi: 10.1002/pon.4021 pubmed: 26525309
Oh PJ, Cho JR (2020) Changes in fatigue, psychological distress, and quality of life after chemotherapy in women with breast cancer: a prospective study. Cancer Nurs 43:54–60
doi: 10.1097/NCC.0000000000000689
Vance V, Mourtzakis M, Hanning R (2019) Relationships between weight change and physical and psychological distress in early-stage breast cancer survivors. Cancer Nurs 42:43–50
doi: 10.1097/NCC.0000000000000612
Philip EJ, Bergerot CD, Clark K, Bergerot P, Loscalzo M (2019) Obesity and psychosocial well-being among cancer patients and survivors. Psychooncology 28:2141–2148
doi: 10.1002/pon.5181 pubmed: 31486137
Kobayashi K, Morita S, Shimonagayoshi M, Kobayashi M, Fujiki Y, Uchida Y, Yamaguchi K (2008) Effects of socioeconomic factors and cancer survivors’ worries on their quality of life (QOL) in Japan. Psychooncology 17:606–611
doi: 10.1002/pon.1278 pubmed: 17972358
Ernst J, Götze H, Krauel K, Romer G, Bergelt C, Flechtner HH, Herzog W, Lehmkuhl U, Keller M, Brähler E, von Klitzing K (2013) Psychological distress in cancer patients with underage children: gender-specific differences. Psychooncology 22:823–828
doi: 10.1002/pon.3070 pubmed: 22461208
Saboonchi F, Petersson LM, Wennman-Larsen A, Alexanderson K, Brännström R, Vaez M (2014) Changes in caseness of anxiety and depression in breast cancer patients during the first year following surgery: patterns of transiency and severity of the distress response. Eur J Oncol Nurs 18:598–604
doi: 10.1016/j.ejon.2014.06.007 pubmed: 24997517
Fayanju OM, Ren Y, Stashko I, Power S, Thornton MJ, Marcom PK, Hyslop T, Hwang ES (2020) Patient‐reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis. Cancer. https://doi.org/10.1002/cncr.33310
doi: 10.1002/cncr.33310 pubmed: 33175437

Auteurs

Holger G Hass (HG)

Klinik Gais, Abteilung Onkologie, Dep. Innere Medizin, Gäbrisstrasse 1172, 9056, Gais, Switzerland. holger.hass@kliniken-valens.ch.
Institut Für Rehabilitationsforschung Und Survivorship (IREFOS), 88175, Scheidegg, Germany. holger.hass@kliniken-valens.ch.

Marianne Seywald (M)

Institut Für Rehabilitationsforschung Und Survivorship (IREFOS), 88175, Scheidegg, Germany.
Paracelsus-Klinik, 88175, Scheidegg, Germany.

Achim Wöckel (A)

Frauenklinik, Universitätsklinikum, 97080, Würzburg, Germany.

Blerta Muco (B)

Universität Würzburg, 97080, Würzburg, Germany.

Miro Tanriverdi (M)

Universität Würzburg, 97080, Würzburg, Germany.

Jürgen Stepien (J)

Institut Für Rehabilitationsforschung Und Survivorship (IREFOS), 88175, Scheidegg, Germany.
Paracelsus-Klinik, 88175, Scheidegg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH